Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk for Invasive Breast Cancer”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Large-scale testing (Phase 3)UnknownNCT00402519
What this trial is testing

APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer

Who this might be right for
Breast Cancer
University of Erlangen-Nürnberg Medical School 1,300
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT02063724
What this trial is testing

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 15
Early research (Phase 1)Study completedNCT03323658
What this trial is testing

Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Ductal Carcinoma In Situ+2 more
National Cancer Institute (NCI) 24
Not applicableNot Yet RecruitingNCT07527468
What this trial is testing

HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery

Who this might be right for
Breast CancerDuctal Carcinoma In SituInvasive Lobular Carcinoma+1 more
Hôpital du Valais 228
Post-approval studies (Phase 4)Looking for participantsNCT04790305
What this trial is testing

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

Who this might be right for
Carcinoma BreastTriple-negative Breast CancerInvasive Ductal Carcinoma, Breast
Fudan University 1,072
Not applicableWithdrawnNCT00312637
What this trial is testing

Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT07806630
What this trial is testing

SHORTened Duration of TAMoxifen

Who this might be right for
High Risk for Invasive Breast Cancer
Rutgers, The State University of New Jersey 250
Early research (Phase 1)Study completedNCT02061423
What this trial is testing

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 7
Large-scale testing (Phase 3)Looking for participantsNCT05059379
What this trial is testing

Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer

Who this might be right for
Breast CancerRadiotherapy; ComplicationsEffect of Radiation Therapy
Fudan University 1,650
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableStudy completedNCT01508273
What this trial is testing

Lifestyle Intervention for High Risk Cancer Survivors

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 1,150
Not applicableLooking for participantsNCT06823414
What this trial is testing

Endoscopy/Robotic Assisted Nipple Skin Sparing Mastectomy

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Cancer Non-invasive Breast CancerHigh Risk Breast Carcinoma
Alejandra García-Novoa 126
Not applicableUnknownNCT04974567
What this trial is testing

Tear Based Sample Collection Breast Cancer Detection

Who this might be right for
Breast CancerTearBreast Cancer Female
Namida Lab 50
Large-scale testing (Phase 3)Active Not RecruitingNCT02488967
What this trial is testing

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

Who this might be right for
Breast AdenocarcinomaEstrogen Receptor NegativeHER2/Neu Negative+7 more
NRG Oncology 782
Large-scale testing (Phase 3)Ended earlyNCT00625898
What this trial is testing

BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab

Who this might be right for
Breast Cancer
NSABP Foundation Inc 3,509
Testing effectiveness (Phase 2)Study completedNCT00073073
What this trial is testing

Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast Neoplasms
Georgetown University 46
Not applicableStudy completedNCT04999917
What this trial is testing

Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer

Who this might be right for
Breast CancerBreast Cancer InvasiveBreast Cancer in Situ
XEOS Medical 206
Testing effectiveness (Phase 2)UnknownNCT02670109
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients

Who this might be right for
Triple-Negative Invasive Breast CarcinomaResidual Tumor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 20
Early research (Phase 1)UnknownNCT03749850
What this trial is testing

Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer

Who this might be right for
Metastatic Breast CancerBreast CancerBreast Neoplasms+5 more
UMC Utrecht 12
Next Page